🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — anyone have experience? Page 2

Pancreatitis risk assessment — anyone have experience?

JenPlateau Sun, Apr 6, 2025 at 6:56 PM 29 replies 1,958 viewsPage 2 of 6
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Apr 6, 2025 at 9:46 PM#6

Excellent points all around. To summarize the red flags that should prompt immediate evaluation:

  • Severe epigastric pain (upper middle/left abdomen) radiating to the back
  • Pain that is constant and worsening over hours, not intermittent
  • Nausea and vomiting accompanying the severe pain
  • Pain that worsens after eating and is not relieved by antacids
  • Fever with abdominal pain

If you experience this constellation, go to the ER. They will check lipase levels and do imaging. But I want to echo — in 15 years of practice, I have had exactly two patients develop pancreatitis on GLP-1 RAs, both had pre-existing risk factors (one had gallstones, one had significant alcohol use). It is genuinely rare.

Contraindications for GLP-1 RAs related to pancreatic risk: personal history of pancreatitis is listed as a precaution (not absolute contraindication) in prescribing information. Discuss with your provider.

Last edited: Apr 7, 2025 at 2:46 AM
3 21nick_newbie, DadBodDave, AmyNC_wife
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Apr 6, 2025 at 10:03 PM#7

Thank you all so much. I feel like I can breathe again. The data really helps — <0.2% is very different from how the article my friend sent made it sound. I have no history of pancreatitis, don't drink, and don't have gallstones. I'm going to keep taking my tirzepatide and stop googling at 2am. 🙃

Last edited: Apr 7, 2025 at 3:03 AM
23 1VendorMark, COA_Karl, MikeFit_NJ and 20 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register